Outcomes and costs of incorporating a multibiomarker disease activity test in the management of patients with rheumatoid arthritis

Objective. The multibiomarker disease activity (MBDA) blood test has been clinically validated as a measure of disease activity in patients with RA. We aimed to estimate the effect of the MBDA test on physical function for patients with RA (based on HAQ), quality-adjusted life years and costs over 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Michaud, Kaleb, Strand, Vibeke, Shadick, Nancy A., Degtiar, Irina, Ford, Kerri, Michalopoulos, Steven N., Hornberger, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536857/
https://www.ncbi.nlm.nih.gov/pubmed/25877911
http://dx.doi.org/10.1093/rheumatology/kev023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536857/
https://www.ncbi.nlm.nih.gov/pubmed/25877911
http://dx.doi.org/10.1093/rheumatology/kev023

Ejemplares similares